Amryt Pharma has acquired 4 companies of its own, including 1 in the last 5 years.
Amryt Pharma’s largest acquisition to date was in 2016, when it acquired SomPharmaceuticals S.A for $46M. Amryt Pharma has acquired in 1 US state, and 3 countries. The Company’s most targeted sectors include life science (100%).
45 Mespil Road 196 High Road Wood Green,
Dublin,
D04 W2F1
Ireland,
+353 1 518 0200
www.amrytpharma.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2021-05-05 |
Chiasma · Life Science
Needham, Massachusetts · www.chiasma.com Chiasma is a commercial-stage biopharmaceutical company focused on developing and commercializing oral therapies to improve the lives of patients who face challenges associated with their existing treatments for rare and serious chronic diseases. Chiasma was incorporated in 2001 and is headquartered in Needham, Massachusetts. Advisors: Goodwin Procter , Torreya Partners |
- | Add-on Acquisition |
Amryt Pharma
|
- |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
